This trial is studying nivolumab and relatlimab to see how well they work in treating chordoma that has spread to other places in the body.
- Unresectable Chordoma
- Metastatic Chordoma
1 Primary · 4 Secondary · Reporting Duration: Up to 2 years
Side Effects for
1 Treatment Group
Treatment (nivolumab and relatlimab)
1 of 1
10 Total Participants · 1 Treatment Group
Primary Treatment: Nivolumab · No Placebo Group · Phase 2
Who is running the clinical trial?
Age Any Age · All Participants · 10 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
What medical issues can be addressed with the administration of Nivolumab?
"Nivolumab is prescribed most frequently to combat malignant neoplasms, though it has also been used in the treatment of various other illnesses like metastatic esophageal adenocarcinoma and unresectable melanoma." - Anonymous Online Contributor
What adverse effects may be associated with the administration of Nivolumab?
"Based on the available evidence, our team has determined Nivolumab to be moderately safe and thus assigned it a 2. Even though Phase 2 indicates that there is some data regarding its safety, no clinical trials have been conducted to evaluate efficacy yet." - Anonymous Online Contributor
Is this study pioneering a new protocol for treatment?
"At present, there are 720 active Nivolumab trials spanning 49 nations and 2355 cities. The pioneering study of this drug, conducted by Ono Pharmaceutical Co. Ltd in 2012, involved 659 participants; it successfully completed its Phase 1 & 2 approval stage. Since then, 252 further research studies have been undertaken on the subject matter." - Anonymous Online Contributor
What is the capacity of this trial in terms of participants?
"Affirmative. According to clinicaltrials.gov, the trial is still in recruitment mode, having been posted on April 3rd 2019 and modified as of September 16th 2022. 20 participants are sought from a single medical facility." - Anonymous Online Contributor
Are there vacancies available for individuals to partake in this experiment?
"Affirmative. According to the information from clinicaltrials.gov, this trial is presently seeking participants and was first listed on April 3rd 2019 with the last update occurring September 16th 2022. The study requires 20 individuals to be recruited across a single medical site." - Anonymous Online Contributor
Are there other investigations that have utilized Nivolumab?
"There are presently 720 clinical trials for Nivolumab underway, and 82 of them have reached the third phase. Although most investigations originate in Zürich, BE, there are over 40 thousand sites conducting research on this drug." - Anonymous Online Contributor